Recipients
EFSD / Novo Nordisk Type 2 Diabetes Programme



2002 (over 3 years)

Peter Bergsten - Uppsala University - Uppsala, Sweden
Pathophysiology of impaired glucose-induced insulin secretion studied with islet linkage analysis

Ele Ferrannini - Pisa University - Pisa, Italy
Beta-cell dysfunction in type 2 diabetes: quantification, relation to insulin resistance and response to treatment

Jens Juul Holst - Copenhagen University - Copenhagen, Denmark
The role of the incretin hormones in the pathogenesis and the treatment of type 2 diabetes and obesity

Leif Jansson - Uppsala University - Uppsala, Sweden
Islet blood flow and type 2 diabetes

Hubert Kolb - German Diabetes Institute - Düsseldorf, Germany
Immune gene expression and systemic inflammation in the pathogenesis of type 2 diabetes.

Massimo Porta - Turin University - Turin, Italy
Lifestyle intervention by group care in the management of type 2 diabetes. A randomised controlled multicentre clinical trial.

Erik Renström / Sebastian Barg - Lund University - Lund, Sweden
Identification and characterisation of a granular sulphonylurea receptor in the β-cell.

Michael Roden - Vienna University - Vienna, Austria
Metabolic effects of long-term suppression of lipolysis in type 2 diabetes. Nuclear magnetic resonance spectroscopy and stable isotope studies

Frank J. Snoek - Vrije University - Amsterdam, The Netherlands
Onset and recurrence of depression in older persons diagnosed with type 2 diabetes: Who is at risk? A prospective study

Anders Tengholm - Uppsala University - Uppsala, Sweden
Signalling networks for insulin secretion in individual pancreatic β-cells

Emile Van Schaftingen - Louvain Catholic University - Brussels, Belgium
Fructosamine 3-kinase, intracellular fructosamine removal and diabetes complications